Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis.
about
Pharmacologic Treatment for Pediatric Gastroparesis: A Review of the LiteratureRETRACTED: Interventions That Affect Gastrointestinal Motility in Hospitalized Adult Patients: A Systematic Review and Meta-Analysis of Double-Blind Placebo-Controlled Randomized TrialsDisorders of gastrointestinal hypomotilityNovel therapeutic agents in neurogastroenterology: advances in the past year.Rectal sensitivity in diabetes patients with symptoms of gastroparesis.Ghrelin and motilin receptor agonists: time to introduce bias into drug design.Emerging drugs for the treatment of gastroparesis.The investigational drug camicinal for the treatment of gastroparesis.Drug-drug interactions in pharmacologic management of gastroparesis.Peripheral mechanisms in appetite regulation.Case report: rare case of mechanical bowel obstruction due to strangulation by gastric stimulator electrodes.Outcomes and Factors Associated With Reduced Symptoms in Patients With GastroparesisA ghrelin agonist fails to show benefit in patients with diabetic gastroparesis: let's not throw the baby out with the bath water.Therapeutic implications of peptide interactions with G-protein-coupled receptors in diabetic vasculopathy.From ischochymia to gastroparesis: proposed mechanisms and preferred management of dyspepsia over the centuries.Ghrelin receptor modulators: a patent review (2011 - 2014).Neuroenteric Stimulation for Gastroparesis.The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease.Ghrelin and motilin receptors as drug targets for gastrointestinal disorders.From Harmful Treatment to Secondary Gain: Adverse Event Reporting in Dyspepsia and Gastroparesis.Chronic nausea and vomiting: insights into underlying mechanisms.Management of gastroparesis: beyond basics.Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis.Time trends in gastroparesis treatment.Functional dyspepsia and duodenal eosinophilia: A new model.Diabetes and the Stomach.Glass half empty? Lessons learned about gastroparesis.
P2860
Q26747576-C8269985-D8E1-4E12-9184-D0A96EB15F0EQ26769038-A991B5E4-2D45-4384-9A7B-C2D329359036Q28070278-E7FB14CC-1BE2-40B3-BE43-6C81098B0DE6Q33934623-EB75ED10-6AAE-4A5E-BA7B-FC65FEBF270FQ34033661-C2A961C6-8482-4137-94F2-2921D540805EQ34398651-1B4D371A-8691-4481-B75F-1318E8AD3D13Q34412103-542AC875-D06F-4857-AF45-AC4A523EBB1FQ34444648-3F7239D0-52E5-4860-B382-E177A8E7F486Q34480053-68A02E01-BBDF-4F58-8932-0E77E20157CEQ35204654-A1549599-DF62-4E4E-A660-DCC657FC693FQ35237884-2932BF38-DD50-4E74-9C8A-67A6DBEF07CEQ36328386-F302F105-984C-4A5D-9AC8-3050567F6CC5Q38133838-F8D4BE74-14E4-4903-9E89-400C6E78A627Q38196857-8778BCED-C70A-458D-8B62-01D38463DC2EQ38203217-C0CB71AB-0206-46C6-A398-33090147F9D5Q38232345-54EF13DA-94A4-4471-9748-D89E94CB4C80Q38581668-27AE615D-5A32-44FF-B709-B0D592204BD6Q38587559-A749D82D-34F6-4A42-BFC6-C2474867BD10Q38590705-26AA0598-7567-4CEF-B13C-E9B7E8495801Q38747262-146F6BB6-534E-4F1E-BF4D-E5635B4E5FD7Q38815458-E6E39E26-9000-4D9E-BF25-A1AD74A26D76Q39125102-62099400-ABD4-4189-81A0-50FDA53D1CEEQ39892340-1586DEE6-DC84-4626-8F65-9AA306B6F63EQ43546348-731A1BCD-3766-4647-B806-122D586FE478Q47691689-10788E65-96C7-4AF6-9C37-1A92651411C0Q53083035-BA8DEE00-83C3-43A7-9448-33CA6933979EQ54959864-0469416C-79A6-401F-AE86-7BB0F91A3F31
P2860
Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Phase 2b, randomized, double-b ...... st for diabetic gastroparesis.
@en
Phase 2b, randomized, double-b ...... st for diabetic gastroparesis.
@nl
type
label
Phase 2b, randomized, double-b ...... st for diabetic gastroparesis.
@en
Phase 2b, randomized, double-b ...... st for diabetic gastroparesis.
@nl
prefLabel
Phase 2b, randomized, double-b ...... st for diabetic gastroparesis.
@en
Phase 2b, randomized, double-b ...... st for diabetic gastroparesis.
@nl
P2093
P2860
P356
P1476
Phase 2b, randomized, double-b ...... st for diabetic gastroparesis.
@en
P2093
B R Bhandari
C Cosentino
F Rousseau
N Ejskjaer
R W McCallum
T Esfandyari
P2860
P304
P356
10.1111/NMO.12184
P577
2013-07-15T00:00:00Z